Uncovering the genetic and cellular impacts of smoking
Epigenetic data assessing the effects of smoking on DNA methylation could serve as biomarkers of exposure effects.
List view / Grid view
Epigenetic data assessing the effects of smoking on DNA methylation could serve as biomarkers of exposure effects.
A urine-based test that detects ctDNA from HPV-positive head and neck cancers could facilitate its early detection.
New findings about how long genes become less active with age could impact treatments for neurodegeneration, among other conditions.
New understanding of the CRC and its interaction with STAT3 could lead to novel therapeutics and combination strategies.
New findings will enable the development of safer PARP inhibitors that inhibit PARP’s enzymatic activity without trapping it on DNA.
In this Q&A, Aki Ko, CEO and co-founder of Elixirgen Therapeutics, elucidates how their new mRNA technology could potentially restore muscle function in those suffering from Duchenne muscular dystrophy.
Scientists have reported a promising technique, based on somatic cell nuclear transfer, to treat infertility.
Researchers have developed an algorithm which could improve diagnostics of ovarian high-grade serous carcinoma.
Researchers find that the RAD51 protein prevents genomic duplications that could arise from reactivated origins.
Dr Amber Van Laar shares her remarkable journey in STEM. From a childhood fascination with science and medicine to a pivotal role as VP Clinical Development, AskBio. In this interview, she explores the profound impact of her early exposure to neuro-oncology, the challenges faced as a physician-scientist, and the pursuit…
Researchers have developed the world’s first animal model with A-to-G mtDNA edits achieved using engineered TALEDs.
Researchers suggest that DA histology slowly emerges by accumulating burdens of DNA damage and copy number aberrations.
A deep learning model developed using circulating cell-free DNA outperformed traditional screening methods for gestational diabetes mellitus.
For the first time, mitochondrial DNA mutations could be used with immunotherapy to increase the chances of successful treatments.
PLK4 inhibition could be a novel therapeutic for an acute myeloid leukaemia subtype carrying the TP53 mutation.